Monaco: Noncommunicable diseases (NCD) country profile

Introduction

This country profile visualizes selected Global Monitoring Framework (GMF) and Progress Monitor (PM) indicators. GMF data are taken from the Global Health Observatory (GHO) and the European health for all (HFA) database . PM indicators assess the implementation of “best buy” (recommended) policies for the governance, surveillance, prevention and management of NCD. Full names and definitions of indicators, as well as data, are given in PM 2015 and PM 2017.

GMF indicators

Outcomes

Target 1: 25% relative reduction in the overall mortality from cardiovascular diseases, cancer, diabetes and chronic respiratory diseases

Unconditional probability of dying between ages of 30 and 70 from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases

Fig.1: Unconditional probability of dying between ages 30 and 69 years from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by sex, 1990 to latest available data.

Fig.2: Unconditional probability of dying between ages 30 and 69 years from diseases of the circulatory system by sex, 1990 to latest available data.

Fig.3: Unconditional probability of dying between ages 30 and 69 years from cancers by sex, 1990 to latest available data.

Fig.4: Unconditional probability of dying between ages 30 and 69 years from chronic respiratory diseases by sex, 1990 to latest available data.

Fig.5: Unconditional probability of dying between ages 30 and 69 years from diabetes by sex, 1990 to latest available data.

Cancer incidence, by type of cancer, per 100 000 population

Fig.6: Cancer incidence by sex, 1990 to latest available data.

Fig.7: Incidence of trachea, bronchus and lung cancer by sex, 1990 to latest available data.

Fig.8: Incidence of female breast and cervix uteri cancers, 1990 to latest available data.

Behavioural risk factors

Target 2: At least 10% relative reduction in the harmful use of alcohol, as appropriate, within the national context

Total (recorded and unrecorded) alcohol per capita (aged 15+ years old) consumption within a calendar year in litres of pure alcohol, as appropriate, within the national context

Fig.9: Total (recorded and unrecorded) adult alcohol per capita consumption, 1990 to latest available data.

Age-standardized prevalence of heavy episodic drinking among adolescents and adults, as appropriate, within the national context

Fig.10: Age-standardized heavy episodic drinking (defined as 60 grams or more of pure alcohol on at least one occasion in the past 30 days) among adults aged 15 years or more with 95% confidence intervals, latest available data (WHO estimates).

Target 5: A 10% relative reduction in prevalence of insufficient physical activity

Age-standardized prevalence of insufficiently physically active persons aged 18+ years (defined as less than 150 minutes of moderate-intensity activity per week, or equivalent)

Fig.11: Age-standardized prevalence of insufficient physical activity among adults aged 18+ years, latest available data (WHO estimates).

Target 5: A 30% relative reduction in prevalence of current tobacco use

Age-standardized prevalence of current tobacco use among persons aged 18+ years

Fig.12: Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, latest available data (WHO estimates).

Biological risk factors

Target 6: A 25% relative reduction in the prevalence of raised blood pressure or contain the prevalence of raised blood pressure, according to national circumstances

Age-standardized prevalence of raised blood pressure among persons aged 18+ years and mean systolic blood pressure

Fig.13: Age-standardized prevalence of raised blood pressure, defined as systolic blood pressure greater or equal to 140 mmHg and/or diastolic blood pressure greater or equal to 90 mmHg, 1990 to latest available data (WHO estimates).

Fig.14: Age-standardized mean systolic blood pressure, 1990 to latest available data (WHO estimates).

Target 7: Halt the rise in diabetes & obesity

Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years

Fig.16: Age-standardized prevalence of raised blood glucose or diabetes among persons aged 18+ years with 95% confidence intervals, 1990 to latest available year (WHO estimates).

Age-standardized prevalence of overweight and obesity in persons aged 18+ years

Fig.17: Age-standardized prevalence of overweight among persons aged 18+ years, 1990 to latest available data (WHO estimates).

Fig.18: Age-standardized prevalence of obesity among persons aged 18+ years, 1990 to latest available data (WHO estimates).

Additional indicators

Fig.19: Age-standardized prevalence of raised total cholesterol with 95% confidence interval among people aged 15 years and over, latest available data (WHO estimates).

Fig.20: Age-standardized mean total cholesterol with 95% confidence interval, latest available data (WHO estimates).

Fig.21: Proportion of infants vaccinated against hepatitis B.

PM indicators

Indicator	2015		2017
	Monaco	Fully implemented in % of countries	Monaco	Fully implemented in % of countries
I1: Setting national targets and indicators for monitoring and evaluation of progress	1. not achieved	23%	1. not achieved	30%
I2: Strengthening existing mortality and disease registries	3. fully achieved	77%	2. partially achieved	81%
I3: Risk factors surveys	0. no data / unknown	40%	1. not achieved	19%
I4: Development and implementation of national multisectoral NCD policies and action plans	1. not achieved	43%	1. not achieved	66%
I5a: Tobacco demand-reduction measures - Taxation	0. no data / unknown	2%	0. no data / unknown	47%
I5b: Tobacco demand-reduction measures - Smoke-free environments	2. partially achieved	19%	2. partially achieved	25%
I5c: Tobacco demand-reduction measures - Health warnings	1. not achieved	6%	1. not achieved	60%
I5d: Tobacco demand-reduction measures - Advertising bans	1. not achieved	8%	1. not achieved	9%
I5e: Tobacco demand-reduction measures - Mass media campaigns	0. no data / unknown	0%	0. no data / unknown	23%
I6a: Harmful use of alcohol reduction measures - regulations over commercial and public availability of alcohol	2. partially achieved	2%	2. partially achieved	2%
I6b: Harmful use of alcohol reduction measures - comprehensive restrictions or bans on alcohol advertising and promotions	2. partially achieved	30%	1. not achieved	36%
I6c: Harmful use of alcohol reduction measures - pricing policies such as excise tax increases on alcoholic beverages	3. fully achieved	21%	2. partially achieved	13%
I7a: Unhealthy diet reduction measures - Salt/sodium consumption	0. no data / unknown	58%	1. not achieved	47%
I7b: Unhealthy diet reduction measures - Saturated fats and trans-fats	0. no data / unknown	42%	3. fully achieved	62%
I7c: Unhealthy diet reduction measures - Marketing of foods and non-alcoholic beverages to children	0. no data / unknown	42%	1. not achieved	66%
I7d: Unhealthy diet reduction measures - Marketing restrictions of breast-milk substitutes	0. no data / unknown	55%	0. no data / unknown	6%
I8: Promoting awareness on diet and physical activity	0. no data / unknown	75%	3. fully achieved	70%
I10: Assessment and management of cardiometabolic risk factors	0. no data / unknown	30%	3. fully achieved	58%